People: ImmuCell Corp (ICCC.PH)

ICCC.PH on Philadelphia Stock Exchange

--USD
--
Price Change (% chg)

-- (--)
Prev Close
--
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
--
52-wk Low
--

Search Stocks

Summary

Name Age Since Current Position

Joseph Crabb

 57 2009 Chairman of the Board

Michael Brigham

 51 2000 President, Chief Executive Officer, Treasurer, Secretary, Director

David Cunningham

 46 2011 Independent Director

William Maxwell

 73 1986 Independent Director

Linda Rhodes

 62 2005 Independent Director

Jonathan Rothschild

 58 2001 Independent Director

David Tomsche

 55 2006 Independent Director
» Insider Trading

Biographies

Name Description

Joseph Crabb

 Dr. Joseph H. Crabb, Ph.D., serves as Chairman of the Board of ImmuCell Corp., since June 2009. He was appointed a Director of the Company in March 2001, having previously served in that capacity during the period from March 1999 until February 2000. Before that, he was elected Vice President of the Company in December 1998, while maintaining the title of Chief Scientific Officer. He has served as Chief Scientific Officer since September 1998. Prior to that, he served as Vice President of Research and Development since March 1996. Prior to that, he served as Director of Research and Development and Senior Scientist since originally joining the Company in November 1988. He is currently a reviewer for several peer-reviewed journals. Concurrent with his employment, he has served on five study sections at the National Institutes of Health and held three adjunct faculty positions. Prior to joining the Company in 1988, Dr. Crabb earned his Ph.D. in Biochemistry from Dartmouth Medical School and completed postdoctoral studies in microbial pathogenesis at Harvard Medical School, where he also served on the faculty.

Michael Brigham

 Mr. Michael F. Brigham serves as President, Chief Executive Officer, Treasurer, Secretary, Director of ImmuCell Corp. Mr. Brigham was appointed to serve as President and Chief Executive Officer in February 2000, while maintaining the titles of Treasurer and Secretary, and was appointed to serve as a Director of the Company in March 1999. He previously had been elected Vice President of the Company in December 1998 and served as Chief Financial Officer since October 1991. He has served as Secretary since December 1995 and as Treasurer since October 1991. Prior to that, he served as Director of Finance and Administration since originally joining the Company in September 1989. Mr. Brigham joined the Board of Directors of the United Way of York County in 2011, serving as Treasurer. Mr. Brigham served as the Treasurer of the Board of Trustees of the Kennebunk Free Library from 2005 to 2011. Prior to joining the Company, he was employed as an audit manager for the public accounting firm of Ernst & Young. Mr. Brigham earned his Masters in Business Administration from New York University in 1989.

David Cunningham

 Mr. David S. Cunningham serves as an Independent Director of ImmuCell Corp., since September 07, 2011. Mr. Cunningham is President and CEO of Teva Animal Health located in St. Joseph, Missouri. He was previously Executive Vice President of Sales and Marketing for Agri Laboratories Ltd. and before that Vice President of Sales and Marketing, Cattle Division, for Boehringer Ingelheim Vetmedica, Inc. Previously, he worked for Hoechst-Roussel Vet and Lextron Animal Health. Mr. Cunningham is a graduate of Iowa State University.

William Maxwell

 Dr. William H. Maxwell, M.D., serves as an Independent Director of ImmuCell Corp. Dr. Maxwell is a member of the Compensation and Stock Option Committee and the Audit Committee of the Board of Directors. He was President of Maxwell, Kluger, Makaretz M.D., P.A., ENT Associates (MKM) from its inception in 1973 through September 2010, working as an otolaryngologist (head and neck surgeon). He continues to work in the specialty of hearing, tinnitus and balance in private practice. He is Chairman of the Board of Medical Network, Inc. (a Maine PPO). Previously, he served as President and CEO of Medical Mutual Insurance Company of Maine from 1978 to 1999.

Linda Rhodes

 Dr. Linda Rhodes, V.M.D., Ph.D., serves as an Independent Director of ImmuCell Corp. Dr. Rhodes is chair of the Compensation and Stock Option Committee and a member of the Audit Committee of the Board of Directors. Since February 1, 2011, Dr. Rhodes has been CEO of Aratana Therapeutics, a venture capital backed start-up company developing new drugs for companion animals. From 2001-2010, she was a founding partner and Vice President of AlcheraBio, LLC, an animal health consulting and contract research firm, which firm was acquired in October 2008 by Argenta, a New Zealand animal health formulations and contract manufacturing organization (operating as AlcheraBio in the US). She is an adjunct professor for the Graduate School of Animal Science at Rutgers University and is a member of the Board of Directors of the Alliance for Contraception in Cats and Dogs (a non-profit organization). From 1998 to 2001, she was a Director of Development Projects and New Technology Assessment at Merial Ltd. Prior to that, she held various research positions at Merck Research Laboratories and Sterling Drug Company. She held several teaching positions and worked as a bovine veterinarian in private practice. She earned her Ph.D. in Physiology/Immunology from Cornell University and her V.M.D. from the Pennsylvania School of Veterinary Medicine.

Jonathan Rothschild

 Mr. Jonathan E.Rothschild serves as an Independent Director of ImmuCell Corp. Mr. Rothschild is chair of the Nominating Committee and a member of the Compensation and Stock Option Committee and of the Audit Committee of the Board of Directors. Since 1981, he has been President of Arterio, Inc., of Concord, California, a vitamin and nutrition company that does business as Ecological Formulas. He served as a director and Chief Financial Officer of Cistron Biotechnology from 1999 until it was acquired by Celltech, PLC in November 2000.

David Tomsche

 Dr. David S. Tomsche, D.V.M., serves as an Independent Director of ImmuCell Corp. Dr. Tomsche is a member of the Nominating Committee of the Board of Directors. He is a animal veterinarian and controlling owner of Stearns Veterinary Outlet, Inc. (a veterinary distribution company) and of J-t of Melrose, Inc. (an international export company). He has been a director of Agricultural Solutions, Inc. since June 2008. He served as a director of VetPharm, Inc, an animal health products distributor, from 1995 until the company was sold in 2007. He also is a dairy producer. He obtained his degrees from the University of Minnesota.

Basic Compensation

Name Fiscal Year Total

Joseph Crabb

 102,800

Michael Brigham

 206,827

David Cunningham

 --

William Maxwell

 --

Linda Rhodes

 --

Jonathan Rothschild

 --

David Tomsche

 --
As Of 30 Dec 2011

Options Compensation

Name Options Value

Joseph Crabb

 148,436 386,053

Michael Brigham

 128,436 342,468

David Cunningham

 0 0

William Maxwell

 0 0

Linda Rhodes

 0 0

Jonathan Rothschild

 0 0

David Tomsche

 0 0

Insider Trading

Name Shares Traded Price

CRABB JOSEPH H

 1,000 $3.20

BRIGHAM MICHAEL F

 618 $5.17

BRIGHAM MICHAEL F

 1,000 $3.20

TOMSCHE DAVID SCOTT

 15,000 $5.80

TOMSCHE DAVID SCOTT

 206 $6.80

TOMSCHE DAVID SCOTT

 100 $6.50

TOMSCHE DAVID SCOTT

 567 $6.53

TOMSCHE DAVID SCOTT

 1,000 $6.66

TOMSCHE DAVID SCOTT

 762 $6.24

TOMSCHE DAVID SCOTT

 775 $6.25

TOMSCHE DAVID SCOTT

 785 $6.24
» Full list on Insider Trading
Search Stocks